Aegera Therapeutics, Inc.

Pharmascience Inc.

Jon P Durkin

James B Jaquith

Alain Boudreault

Stephen J Morris

John W Gillard

H Nicholas Marsh

Eric LaCasse

Daniel McManus

Kimberley E Hewitt

Gerald Villeneuve

Kimberly Hewitt

The invention features methods, compositions, and kits for treating a patient having a proliferative disease.

Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent

This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I: 

[object Object]

Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides

The present invention features nucleobase oligomers that hybridize to IAP polynucleotide, and methods for using them to enhance apoptosis and treat proliferative disorders.

Antisense IAP nucleobase oligomers and uses thereof

This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. 

Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides

The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis and treat proliferative diseases.

Growing community of inventors

Montreal, Canada

Jon P Durkin